The Potential of Exosomes for Osteoporosis Treatment: A Review
Yinxi He,Yanxia Chen
DOI: https://doi.org/10.2147/dddt.s437596
IF: 4.3188
2024-03-29
Drug Design Development and Therapy
Abstract:Yinxi He, 1 Yanxia Chen 2 1 Department of Orthopaedic Trauma, The Third Hospital of Shijiazhuang, Shijiazhuang, Hebei, 050000, People's Republic of China; 2 Department of Endocrinology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, People's Republic of China Correspondence: Yanxia Chen, Department of Endocrinology, the Second Hospital of Hebei Medical University, 215 Hepingxi Road, Shijiazhuang, Hebei, 050000, People's Republic of China, Email As a continuous process comprising bone resorption and formation, bone remodeling, plays an essential role in maintaining the balance of bone metabolism. One type of metabolic osteopathy is osteoporosis, which is defined by low bone mass and deteriorating bone microstructure. Osteoporosis patients are more likely to experience frequent osteoporotic fractures, which makes osteoporosis prevention and treatment crucial. A growing body of research has revealed that exosomes, which are homogenous vesicles released by most cell types, play a major role in mediating a number of pathophysiological processes, including osteoporosis. Exosomes may act as a mediator in cell-to-cell communication and offer a fresh perspective on information sharing. This review discusses the characteristics of exosomes and outlines the exosomes' underlying mechanism that contributes to the onset of osteoporosis. Recent years have seen a rise in interest in the role of exosomes in osteoporosis, which has given rise to innovative therapeutic approaches for the disease prevention and management. Keywords: exosomes, extracellular vesicles, osteoporosis, osteoblast function, osteoclast function Extracellular vesicles (EVs) have been examined extensively, and exosomes are one such kind. Almost all types of cells release EVs, precisely, tiny, submicron-sized lipid-bilayer-enclosed vesicles, into the extracellular environment. 1 EVs can be categorized into three primary groups based on their size, structure, and biogenesis: exosomes (30–200 nm in diameter), microvesicles (100–1000 nm in diameter), and apoptotic bodies (1–5 μm in diameter). 2 Every type of EV has a unique process of formation. When multivesicular bodies (MVBs) fuse with the plasma membrane, the inward budding of the MVBs' membrane generates homogenous vesicles called exosomes, which are subsequently released into the extracellular environment. 3 Microvesicles (MVs), which originate from direct protrusions of the cell membrane that detach from the surface, are directly released into the extracellular environment. 4 Apoptotic bodies are generated by shedding cells when the cells undergo apoptosis 5 (Figure 1). Figure 1 Schematic representation of the biogenesis of extracellular vesicles (EVs). EVs are formed according to mechanisms specific to the type of EVs. Exosomes (30–200nm) are generated by intraluminal buds fusing with the cell membranes. Initially, the cell membrane invaginates or endocytose to form the early endosome. Early endosomes invaginates to form late endosomes which incorporates endocytic vesicles. Then, the late endosomal membrane invaginates to generate intraluminal vesicles in the lumen of the multivesicular bodies (MVBs). The exosomes are released into extracellular space through exocytosis when the MVBs fuse with the plasma membrane. Microvesicles (100–1000nm) are generated directly from outward budding of the cell membrane. Apoptotic bodies (1–5μm) are directly generated by outward blebbing from apoptotic cells. Exosomes were first discovered in the in vitro culture of sheep reticulocytes. 6,7 Exosomes can be secreted by nearly all mammalian cell types (such as endothelial cells, neuronal cells, muscle cells, hematopoietic cells, and various tumor cells) in physiological and pathological conditions. 8 Various biological fluids, for instance, plasma, serum, urine, cerebral spinal fluid, amniotic fluid, saliva, semen, and breast milk naturally contain exosomes. 9 The exosomes display pronounced molecular heterogeneity, mainly including their size, content, cellular origin, and functional impact on recipient cells. 10 The heterogeneity of exosomes might be an outcome of cellular origin, uneven invagination of MVBs, metabolic status, and the microenvironment of cells. 11 Initially underestimated as molecular garbage bins, exosomes have gained considerable attention as a novel and potent mechanism of intercellular communication. 12 Exosomes can transfer biological signals to modulate target cell biology and function in physiological and pathological processes. 13 Exosomes can carry diverse constituents, including nucleic acids (DNA, mRNA, and noncoding RNA), proteins, lipids, amino acids, and metabolites to p -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal